This video demonstrates accessing multiple nodal stations, including a contralateral nodal station, from a right VATS approach.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
August 7, 2017
Ghoneim and colleagues retrospectively evaluated surgical risk caused by prior mediastinal radiation therapy (MRT) in patients undergoing aortic valve replacement (AVR).
June 19, 2017
Chudgar and colleagues evaluated clinicopathologic variables and characteristics of treatment for 539 patients who had undergone pulmonary metastasectomy for soft-tissue sarcoma at the Memorial Sloan Kettering Cancer Center.
May 11, 2017
I was moved by this editorial on global health matters in a daily British newspaper by an academic medical colleague, written in response to anticipated changes in the leadership of the World Health Organisation. It is perhaps time for us surgeons to augment our administrative participation in global healthcare.
November 1, 2016
An interesting case series of cardiotoxicity of modern chemotherapy attempting to elucidate mechanisms of heart failure.
August 26, 2015
Investigators from Stanford developed a nine-gene expression predictor for survival outcome in early-stage nonsquamous NSCLC. They developed and validated a quantitative real-time polymerase chain reaction assay easily applicable to routinely obtained paraffin-embedded tumor specimens.
June 16, 2015
Data from a variety of US sources were used to estimate the contribution of smoking to mortality for 12 common malignancies (colorectal, esophagus, kidney, larynx, liver, lung, leukemia, head/neck, pancreas, stomach, bladder, cervix. The contribution of smoking to mortality ranged from 10% (colorectal) to 77% (larynx). The overall contribution was
April 13, 2015
This retrospective case-control study involving 1852 Hodgkin lymphoma 5-year survivors found that radiation to the heart valves tend to increase the risk for clinically significant valvular heart disease. The rate increased 3.1-fold in patients receiving 31-35 Gy and 11.8-fold in those who received > 40 Gy.
December 18, 2014
This randomized trial in New Zealand assigned smokers who wished to quit to either nicotrine replacement therapy or cytisine therapy.
June 25, 2014
In this study presented by Dr. Joshua A. Roth recently at the ASCO meeting, they used a model to forecast the 5-year results of implementation of a screening program (as suggest the NLST, age older than 55 with at least 30 pack-years of smoking history) in comparison to no screening program.